REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioavante Capital Sas (Colombia)

Main Activities: Securities Brokerage
Full name: Bioavante Capital Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Bioavante Capital Sas is an enterprise in Colombia, with the main office in Bogota D.C.. The company operates in the Securities Brokerage industry. It was incorporated on November 26, 2015. The company’s latest financial report indicates a net sales revenue drop of 92.56% in 2023. During that time, Bioavante Capital Sas’s total assets decreased by 96.23%. The net profit margin of Bioavante Capital Sas decreased by 27.72% in 2023.

Headquarters
Calle 127 A 7 19 Oficina 205
Bogota D.C.; Bogota D.C; Postal Code: 1003

Contact Details: Purchase the Bioavante Capital Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Bioavante Capital Sas report to view the information.
Incorporation Date:
November 26, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Company Performance
Financial values in the chart are available after Bioavante Capital Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-92.56%
Total operating revenue
-92.56%
Operating profit (EBIT)
-95.75%
Net Profit (Loss) for the Period
-94.72%
Total assets
-96.23%
Total equity
-97.7%
Operating Profit Margin (ROS)
-41.62%
Net Profit Margin
-27.72%
Return on Equity (ROE)
74.07%
Quick Ratio
-4.8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?